Statistics

Total Visits

Views
Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trial46

Select a period of time:

Number of views in the range

Views
Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trial14

Views

Views
July 202511
August 20250
September 20250
October 20251
November 20250
December 20252
January 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil9
Canada2
Turkey1
United States1
South Africa1
 

Top cities views

Views
Antakya1
Araruna1
Blumenau1
Butiá1
Campinas1
Campo Bom1
Codó1
Durban1
Montreal1
Ribeirão Gabiroba1